Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice
- 22 July 2009
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 57 (7-8) , 687-693
- https://doi.org/10.1016/j.neuropharm.2009.07.025
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodentsPharmacology Biochemistry and Behavior, 2007
- Stimulant Medications: How to Minimize Their Reinforcing Effects?American Journal of Psychiatry, 2006
- Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorderBehavioural Brain Research, 2006
- Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatumDevelopmental Brain Research, 2005
- Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001Journal of Adolescent Health, 2004
- Animal models of attention-deficit hyperactivity disorderBrain Research Reviews, 2003
- In Utero Alcohol and Postnatal Methylphenidate: Locomotion and Dopamine ReceptorsNeurotoxicology and Teratology, 1999
- Autoreceptor Regulation of Dopamine SynthesisAnnals of the New York Academy of Sciences, 1990
- Kinetic Analysis of Enantiomers of Threo-Methylphenidate and Its Metabolite in Two Healthy Subjects after Oral Administration as Determined by a Gas Chromatographic-Mass Spectrometric MethodJournal of Pharmaceutical Sciences, 1990
- Interactions in tissue distribution between methylphenidate and pemoline. II. Effects of methylphenidate or its metabolite on plasma and tissue concentrations of pemoline in the rat.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988